Pinoline
Names | |
---|---|
Preferred IUPAC name
6-Methoxy-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole | |
Other names
6-MeO-THBC; 5-MeO-TLN; Pinoline; 6-Methoxy-2,3,4,9-tetrahydro-1H-β-carboline; 6-Methoxy-1,2,3,4-tetrahydro-β-carboline; 6-Methoxy-tetrahydronorharman; 6-Methoxy-2,3,4,9-tetrahydro-1H-β-carboline
| |
Identifiers | |
3D model (
JSmol ) |
|
ChemSpider | |
ECHA InfoCard
|
100.161.873 |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C12H14N2O | |
Molar mass | 202.257 g·mol−1 |
Melting point | 216 to 224 °C (421 to 435 °F; 489 to 497 K) |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Pinoline is a methoxylated
Bausch & Lomb filed a patent for a drug delivery device utilizing this molecule, designed to treat various ophthalmic disorders in 2006.[5]
Pharmacology
One of pinoline's pharmacological properties is its ability to promote neurogenesis in vitro; even at trace concentrations.[6]
Aluminium toxicity causes an increase in lipid peroxidation, with most damage occurring in the brain. A recent review of studies shows pinoline and melatonin to be effective at reducing the lipid peroxidation. Studies included both human and animal subjects. The studies’ results support that pinoline has antioxidant properties.[citation needed]
Lipopolysaccharide is produced by Gram-negative bacteria and stimulates the production of free radicals which in turn cause lipid peroxidation. A recent study compared the effectiveness of melatonin and other similar compounds on the lipopolysaccharide induced lipid peroxidation. The results showed support for pinoline’s ability to reduce damage from lipid peroxidation[citation needed]. Pinoline was also shown to be more effective than vitamin E at reducing lipopolysaccharide activity in the retina.[7]
Another recent study compared the antioxidant properties of compounds from the tryptophan metabolic pathway in the pineal gland against oxidative damage to the lipids and proteins of
See also
- Norharmane
- harmane
- beta-Carboline
- Harmala alkaloid
References
- PMID 23881860.
- .
- ISBN 978-3-540-00201-7. Retrieved 2009-02-14.
- PMID 726902.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - ^ Bartels, S. P. (2006) U.S. Patent No. 20,060,292,202 Washington, DC: U.S.
- ^ { Mario de la Fuente et al. 2015 "Neurogenic Potential Assessment and Pharmacological Characterization of 6-Methoxy-1,2,3,4-tetrahydro-β-carboline (Pinoline) and Melatonin–Pinoline Hybrids" http://pubs.acs.org/doi/abs/10.1021/acschemneuro.5b00041}
- PMID 22314571.
- PMID 20162018.